C-Reactive Protein/Albumin (Crp/Alb) Ratio as a Predictor of Ovarian Cancer

Authors

  • Budian Budiana Department of Obstetrics and Gynaecology of Prof. IGNG Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Bayu Mahendra Department of Obstetrics and Gynaecology of Prof. IGNG Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Putra Wiradnyana Department of Obstetrics and Gynaecology of Prof. IGNG Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Darmayasa Darmayasa Department of Obstetrics and Gynaecology of Prof. IGNG Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Fajar Marta Department of Obstetrics and Gynaecology of Prof. IGNG Ngoerah Hospital, Denpasar, Bali, Indonesia
  • Suwanpramana Suwanpramana Department of Obstetrics and Gynaecology of Prof. IGNG Ngoerah Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.46799/jhs.v4i5.913

Keywords:

Albumin, C-Reactive Protein, CRP/Albumin Ratio, Diagnostic, Ovarian Cancer

Abstract

Ovarian cancer is a type of cancer with a high incidence and mortality rate in Indonesia and worldwide. C-reactive protein (CRP) is an inflammatory marker meanwhile albumin is an indicator of nutritional deficiencies in ovarian cancer. This study is a diagnostic test for ovarian cancer in women aged >18 years and without previous history of ovarian cancer who underwent laparotomy or laparoscopy at Prof. Ngoerah General Hospital, Denpasar. Samples were taken by consecutive sampling. CRP examination was carried out in the laboratory by immunoturbidimetry method using the CRP Latex Kit (Roche) and measured using a Cobas integra 501 at a wavelength of 552 nm. The gold standard to diagnosed ovarian cancer was according to histopathological examination. A total of 69 women with ovarian tumors were recruited into the study which consisted of 40 ovarian cancers and 29 benign ovarian tumors. A significantly higher median CRP/Albumin ratio was found in ovarian cancer patients compared to benign ovarian tumors (6.9 vs 0.45; p=0.001). The optimal CRP/albumin ratio cut-off value was 1.34. The diagnostic capability of the CRP/Albumin ratio was found to be the best in diagnosing cancer at an advanced stage with a sensitivity of 86.9%, specificity of 68.9%, PPV of 68.9%, NPV of 86.9%, accuracy of 76.9%, positive likelihood ratio 2.8 and negative likelihood ratio 0.2. CRP/Albumin ratio can a potential diagnostic tool for ovarian cancer especially in advanced stage.

Downloads

Published

2023-05-25

Issue

Vol. 4 No. 5 (2023): Journal Health Sains

Section

Articles

License

Copyright (c) 2023 Pande Made Suwanpramana, I Nyoman Gede Budiana, I Nyoman Bayu Mahendra, Anak Agung Gede Putra Wiradnyana, I Made Darmayasa, Kadek Fajar Marta

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.